XVA143

Name: XVA143
Brand: TargetMol
SKU: T40274
Rating: 4.5 (1 reviews)

还可以

产品编号 T40274Cas号 264275-77-6

别名 XVA143

XVA143, an α/β I-like allosteric antagonist, inhibits LFA-1 dependent firm adhesion, while at the same time it enhances adhesion in shear flow and rolling both in vitro and in vivo. XVA143 is an antagonist of both mouse and human CR3, inhibits the ability of P. gingivalis to persist in the mouse host and cause periodontal bone loss.

XVA143

还可以

产品编号 T40274 别名 XVA143Cas号 264275-77-6

规格	价格	库存	数量
25 mg	¥ 10,600	6-8周

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

XVA143 相关产品

产品介绍

生物活性

产品描述	XVA143, an α/β I-like allosteric antagonist, effectively blocks LFA-1 dependent firm adhesion but simultaneously increases adhesion under shear flow and rolling conditions, both in vitro and in vivo.
体外活性	XVA143 (1 μM) completely abolishes binding of ICAM-1 to LFA-1 in Mn 2+ and Mg 2+ /EGTA, with no hint of agonism[1]. XVA143 restores rolling of the α L -E310A β 2 mutant by inducing extension of α L[2]. Cell Viability Assay[1]Cell Line: K562 cells. Concentration: 0, 0.2, 0.5 and 1 μM. Incubation Time: Result: Potent against the weakest activator (2 mM Mg 2+ /1 mM EGTA, IC 50 ~10 -3 nM) and least potent against the strongest activator (1 mM Mn 2+ , IC 50 ~10 -3 nM). Cell Viability Assay[1]Cell Line: Wild-type murine lymphocytes[1]. Concentration: 100 μM. Incubation Time: Result: Induced a 50% increase in rolling fraction compared to vehicle-treated control cells ((from 27±5% to 41±7%).
别名	XVA143